DGAP-News: Evonik Industries AG / Key word(s): Mergers & Acquisitions Evonik Industries AG: Evonik acquires Specialty & Coating Additives business of Air Products 06.05.2016 / 13:27 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Evonik acquires Specialty & Coating Additives business of Air Products - Evonik strengthens leading position in the attractive growth market for specialty & coating additives - Product and customer portfolios are highly complementary - Acquisition secures leading position in North America for Evonik and strengthens innovation - Synergies of 80 million US dollars per year and tax benefits with a net present value of more than 500 million US dollars expected - Financing half with company's own funds and half with additional debt Essen, May 6, 2016 - Evonik Industries AG is acquiring the Specialty & Coating Additives business (Performance Materials Division) of the US company Air Products and Chemicals, Inc. for 3.8 billion US dollars (approx. EUR3.5 billion), strengthening its leading position on the high-margin specialty & coating additives market. The transaction is intended to be completed by the end of the year. It is expected that the acquisition will be EPS accretive for Evonik in the 2017 business year. Klaus Engel, CEO of Evonik Industries AG, said: "Evonik is already one of the leading producers of specialty & coating additives. Air Products' Specialty & Coating Additives business perfectly complements this fast-growing segment. With this acquisition we are expanding our portfolio with precisely the right markets, products and innovations and continuing to invest in our growth and profitability." Rapid integration With its own strategic reorganization and creation of three independent operational segments in 2015, Evonik established the right conditions for integrating major acquisitions. As such, Air Products' Specialty & Coating Additives business can be rapidly integrated into the growth segments Nutrition & Care and Resource Efficiency. The combined specialty & coating additives business has a turnover of around EUR3.5 billion and an attractive EBITDA margin of more than 20%. At the same time, Evonik is further strengthening its leading position in rapidly growing, highly profitable markets with strong differentiation from competitors and low dependence on commodity prices. Highly complementary products and markets With their products and their strong positions in the key global markets, Evonik and the newly acquired business are highly complementary. Their specialty & coating additives add critical and highly valuable characteristics to their customers' products. The two businesses serve three particularly attractive, rapidly growing core markets: coating and adhesive additives, high-value PU foam additives, and specialty surfactants for industrial and institutional cleaning. They target the same end customers, but with different and complementary products. For instance, Evonik is a leader in PU foam stabilizers while the Specialty & Coating Additives business of Air Products is well positioned in PU foam catalysts. Demand for these products is rising strongly, and the market for these additives will grow far more quickly than overall demand for chemical products. Geographically, Evonik and the acquired division also complement each other. While the largest portion of the Air Products' business is in North America and Asia, Evonik is particularly strong in Europe. With the current acquisition, Evonik is crucially boosting its standing in the North American market, allowing it to serve the increasingly global activities of its customers even more effectively. At the same time, by growing in North America and Asia, Evonik is reducing its dependence on the European market and therefore better protecting its own business against economic fluctuations in individual regions. Strengthening innovation Like Evonik, Air Products' Specialty & Coating Additives business follows a solution-oriented business model driven by intensive interaction with customers in research and development and outstanding technical service. The acquisition will allow Evonik to significantly strengthen its innovation leadership. High synergy potential and tax benefits By optimizing production/logistics, marketing/sales and administration, Evonik expects to generate cost synergies of 60 million US dollars per year. These should be fully realized by 2020 at the latest. In addition, Evonik expects to achieve revenue synergies by combining innovation activities, leveraging the respective client bases and product portfolios, and taking advantage of geographical adjacencies. In total, the deal is expected to generate annual synergies of 80 million US dollars. The transaction is partly structured as an asset deal, which will lead to tax benefits which are typical for transactions of this nature. These benefits amount to a net present value of more than 500 million US dollars. Transaction financing Half of the outlay for the acquisition will be financed with the company's own funds, the other half with additional debt. Evonik will maintain a strong balance sheet and continues to aim for a solid investment grade rating after the transaction. The planned acquisition remains subject to formal approvals from the relevant antitrust authorities. Additional information on Air Products' Specialty & Coating Additives business The Specialty & Coating Additives business of Air Products is the Performance Materials Division within the Materials Technologies Segment of Air Products and Chemicals, Inc. In 2015, the business generated a turnover of around 1.1 billion US dollars and posted EBITDA of 242 million US Dollars, which represents a margin of 22%. It has around 1,100 employees at 11 production and development locations and offers local customer support in all key global regions. Company information Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik's corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2015 more than 33,500 employees generated sales of around EUR13.5 billion and an operating profit (adjusted EBITDA) of about EUR2.47 billion. Disclaimer In so far as forecasts or expectations are expressed in this Investor Relations News or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release. Contact: Tim Lange Head of Investor Relations +49 201 177-3150 [email protected] Evonik Industries AG Rellinghauser Straße 1-11 45128 Essen Germany Phone +49 201 177-01 Telefax +49 201 177-3475 www.evonik.com Supervisory Board Dr. Werner Müller, Chairman Executive Board Dr. Klaus Engel, Chairman Dr. Ralph Sven Kaufmann Christian Kullmann Thomas Wessel Ute Wolf Registered office Essen Registered court Essen local court Commercial registry B 19474 VAT ID no. DE 811160003 --------------------------------------------------------------------------- 06.05.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Evonik Industries AG Rellinghauser Straße 1-11 45128 Essen Germany Phone: +49 (0) 201 177-01 Fax: +49 (0) 201 177-3475 E-mail: [email protected] Internet: www.evonik.com ISIN: DE000EVNK013, XS0911405784 WKN: EVNK01, A1TM7T Indices: MDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Hanover, Munich, Stuttgart; Terminbörse EUREX; Luxemburg End of News DGAP News Service --------------------------------------------------------------------------- 461159 06.05.2016